Histamine H3 receptor agents, preparation and therapeutic uses

The present invention provides a novel compound of Formula (I) or a pharmaceutically acceptable salt thereof, having histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another, embodiment, the invention discloses pharmaceutical compositi...

Full description

Saved in:
Bibliographic Details
Main Authors WILLIAM JOSEPH HORNBACK, TERRY PATRICK FINN, TAKAKO TAKAKUWA, DON RICHARD FINLEY, PHILIP ARTHUR HIPSKIND, CYNTHIA DARSHINI JESUDASON
Format Patent
LanguageEnglish
Published 02.03.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a novel compound of Formula (I) or a pharmaceutically acceptable salt thereof, having histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another, embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
Bibliography:Application Number: AU20050277518